Trials / Completed
CompletedNCT01849705
Melanocortin 4 Receptor Mutations and Obesity-associated Diseases
Mutations in the Melanocortin 4 Receptor and Obesity-associated Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 226 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Mutations in the melanocortin 4 receptor (MC4R) are the most common form of monogenic obesity, and can explain 2-6% of severe obesity. Studies have shown that mutations in MC4R are associated with increased fat mass, height-for-age, appetite and insulin resistance among children. In adults, mutations in MC4R are less penetrant for these phenotypes but it has been observed that individuals with MC4R mutations have a smaller than expected blood pressure for their degree of obesity. The purpose of this study is to explore the association between functional MC4R mutations and obesity, insulin resistance and blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2013-05-08
- Last updated
- 2013-05-08
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01849705. Inclusion in this directory is not an endorsement.